Back to results
CompletedPhase 3

Citalopram for Agitation in Alzheimer's Disease

NCT00898807

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Southern California Keck School of Medicine Memory and Aging Center

Los Angeles, California, United States

+7 additional locations

View on ClinicalTrials.gov
Citalopram for Agitation in Alzheimer's Disease — TrialFind